Immunome

Developer of antibody-based therapeutics for treating cancer

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2008 groups37 employees language immunome.com

Registered entities

Innovation

23 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,650 times.

YearFilings
20191
20203
20214
20229
20234
20246
202513
20264

Social engagement

Social engagement: 13.5K social following, 9 posts in the last 12 months — top quartile of its industry.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Angel & family office117%
Other / undisclosed117%

Recent activity

15 Jun 2026
Milestone
regulatory
26 May 2026
Event
ASCO26
29 Apr 2026
Milestone
regulatory
Coming soon